Wegovy has arrived in the UK: the story of the weight-loss jab so far: In February 2021, The Conversation reported on a trial for a new weight-loss drug, called semaglutide, that was being hailed in the media as a “gamechanger”. Gamechanger is a word used far too often by journalists to describe things that are, …
Semaglutide: beware of buying the weight-loss drug online: A few years ago, celebrity weight-control practices were out of most people’s reach. Live-in chefs and personal trainers, not to mention elaborate surgical procedures like the Brazilian butt lift, were not real options for most. But with the advent of drugs such as semaglutide, it seems that …
Wegovy: more people may soon be eligible to access weight-loss drug under new pilot scheme: Wegovy has the same active ingredient as Ozempic. myskin/ Shutterstock One in four adults in the UK are obese. Obesity is associated with many health conditions including high blood pressure, type 2 diabetes, heart attacks, stroke and cancer. The financial …
Wegovy and Ozempic: could the new weight-loss drug also treat dementia?: Over 55 million people worldwide have dementia. This mind-robbing condition has a huge impact on society and the economy, so scientists are working hard to find ways to treat or prevent it. One of the avenues being explored is the new weight-loss jab, Wegovy. …
GPs don’t give useful weight-loss advice – new study: Have you tried eating less and moving more? Monkey Business Images/Shutterstock The advice general practitioners give to patients with obesity in the UK was found to be “highly varied, superficial and often lacked an apparent evidence base”, according to a new study from the University of …